Raymond James Financial’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.19K Buy
20,074
+5,000
+33% +$4.61K ﹤0.01% 5258
2025
Q4
$33.2K Buy
15,074
+2,374
+19% +$3.82K ﹤0.01% 5043
2025
Q3
$20.2K Sell
12,700
-100
-0.8% -$130 ﹤0.01% 4903
2025
Q2
$20.7K Hold
12,800
﹤0.01% 5584
2025
Q1
$15.2K Sell
12,800
-3,600
-22% -$5.75K ﹤0.01% 4740
2024
Q4
$33.8K Buy
+16,400
New +$38.2K ﹤0.01% 4662

Other funds holding GUTS

Raymond James Financial's GUTS Position: Q1 2026 in Review

Raymond James Financial increased its Fractyl Health (GUTS) stake by 33% in Q1 2026, buying an estimated $4.61K and bringing the position to 20,074 shares worth $9.19K. The position accounts for ﹤0.01% of the portfolio, ranked #5258.

Raymond James Financial first reported a position in GUTS in Q4 2024 and has held it in 6 quarters since. The position peaked at $33.8K in Q4 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Raymond James Financial held 20,074 shares of Fractyl Health worth $9.19K as of Q1 2026.
  • Raymond James Financial bought 5,000 Fractyl Health shares in Q1 2026, an estimated $4.61K.
  • Fractyl Health made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #5258 holding.
  • Raymond James Financial first reported a position in Fractyl Health in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Fractyl Health position peaked at $33.8K in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.